Scandion Oncology A/S — Credit Rating and Financial Key Figures

Scandion Oncology A/S (CVR number: 38613391) is a company from KØBENHAVN. The company recorded a gross profit of -11161 kDKK in 2019. The operating profit was -15.4 mDKK, while net earnings were -12.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was -92 %, which can be considered poor and Return on Equity (ROE) was -78.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 92.1 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Scandion Oncology A/S's liquidity measured by quick ratio was 13.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.